MabVax Therapeutics Holdings Inc (OTCQB:MBVX)

2.29
Delayed Data
As of May 22
 -0.09 / -3.78%
Today’s Change
0.83
Today|||52-Week Range
15.00
+25.82%
Year-to-Date
No recent news for MabVax Therapeutics Holdings Inc.

Today’s Trading

Previous close2.38
Today’s open2.42
Day’s range2.26 - 2.42
Volume43,095
Average volume (3 months)121,182
Market cap$53.3M
Dividend yield--
Data as of 3:57pm ET, 05/22/2015

Growth & Valuation

Earnings growth (last year)-1.60%
Earnings growth (this year)--
Earnings growth (next 5 years)+54.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales6.44
Price/Book--

Competitors

No competitors data available.

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$314.2K
Annual profit (last year)-$7.9M
Net profit margin-2,520.20%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
John David Hansen
Chief Financial Officer
Gregory P. Hanson
Corporate headquarters
San Diego, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers